Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Century Therapeutics Insiders Buying or Selling?
Century Therapeutics (IPSC) has had 5 insider transactions in the past 90 days, all sells. The most recent was Gregory Russotti, who sold 2,587 shares at $1.93 on September 14, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the IPSC AI Score. For government officials trading this stock, see IPSC congressional trading.
Who’s Trading Century Therapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Brent Pfeiffenberger | Sold $60,000 | 8 | Dec 12, 2025 |
| Chad Cowan | Bought $49,000 | 2 | Dec 22, 2025 |
| Gregory Russotti | Sold $42,000 | 10 | Sep 14, 2026 |
| Douglas Carr | Sold $33,000 | 18 | Sep 14, 2026 |
| Adrienne Farid | Sold $4,400 | 5 | Jun 9, 2025 |
Recent Century Therapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Gregory Russotti | Sep 14, 2026 | Sell | 2,587 | $1.93 | $5,000 |
| Douglas Carr | Sep 14, 2026 | Sell | 1,658 | $1.93 | $3,200 |
| Gregory Russotti | Sep 8, 2026 | Sell | 534 | $2.05 | $1,100 |
| Douglas Carr | Sep 8, 2026 | Sell | 254 | $2.05 | $520 |
| Douglas Carr | Aug 3, 2026 | Sell | 275 | $1.98 | $540 |
| Gregory Russotti | Jun 12, 2026 | Sell | 2,584 | $2.23 | $5,800 |
| Douglas Carr | Jun 12, 2026 | Sell | 1,654 | $2.23 | $3,700 |
| Gregory Russotti | Jun 8, 2026 | Sell | 524 | $2.11 | $1,100 |
| Douglas Carr | Jun 8, 2026 | Sell | 249 | $2.11 | $530 |
| Douglas Carr | May 4, 2026 | Sell | 264 | $2.34 | $620 |
| Gregory Russotti | Mar 12, 2026 | Sell | 10,076 | $2.55 | $26,000 |
| Douglas Carr | Mar 12, 2026 | Sell | 7,043 | $2.55 | $18,000 |
| Gregory Russotti | Mar 9, 2026 | Sell | 479 | $2.54 | $1,200 |
| Douglas Carr | Mar 9, 2026 | Sell | 247 | $2.54 | $630 |
| Douglas Carr | Feb 3, 2026 | Sell | 323 | $1.82 | $590 |
| Chad Cowan | Dec 22, 2025 | Buy | 58,060 | $0.85 | $49,000 |
| Brent Pfeiffenberger | Dec 12, 2025 | Buy | 52,000 | $0.58 | $30,000 |
| Gregory Russotti | Dec 8, 2025 | Sell | 526 | $0.53 | $280 |
| Douglas Carr | Dec 8, 2025 | Sell | 257 | $0.53 | $140 |
| Chad Cowan | Nov 20, 2025 | Sell | 5,462 | $0.5 | $2,700 |
| Brent Pfeiffenberger | Nov 19, 2025 | Buy | 35,000 | $0.5 | $17,000 |
| Brent Pfeiffenberger | Nov 17, 2025 | Sell | 32,456 | $0.45 | $15,000 |
| Douglas Carr | Nov 3, 2025 | Sell | 292 | $0.59 | $170 |
| Douglas Carr | Sep 8, 2025 | Sell | 263 | $0.5 | $130 |
| Brent Pfeiffenberger | Sep 8, 2025 | Sell | 488 | $0.5 | $240 |
| Gregory Russotti | Sep 8, 2025 | Sell | 539 | $0.5 | $270 |
| Douglas Carr | Aug 4, 2025 | Sell | 296 | $0.53 | $160 |
| Douglas Carr | Jun 9, 2025 | Sell | 4,904 | $0.62 | $3,100 |
| Adrienne Farid | Jun 9, 2025 | Sell | 552 | $0.62 | $340 |
| Brent Pfeiffenberger | Jun 9, 2025 | Sell | 475 | $0.62 | $300 |
| Gregory Russotti | Jun 9, 2025 | Sell | 526 | $0.62 | $330 |
| Brent Pfeiffenberger | May 16, 2025 | Sell | 29,552 | $0.55 | $16,000 |
| Adrienne Farid | May 5, 2025 | Sell | 1,024 | $0.55 | $560 |
| Douglas Carr | May 5, 2025 | Sell | 295 | $0.55 | $160 |
| Brent Pfeiffenberger | Mar 10, 2025 | Sell | 2,235 | $0.62 | $1,400 |
| Gregory Russotti | Mar 10, 2025 | Sell | 2,360 | $0.62 | $1,500 |
| Adrienne Farid | Mar 10, 2025 | Sell | 2,359 | $0.62 | $1,500 |
| Douglas Carr | Mar 10, 2025 | Sell | 1,240 | $0.62 | $760 |
| Brent Pfeiffenberger | Feb 18, 2025 | Sell | 34,712 | $0.78 | $27,000 |
| Adrienne Farid | Feb 3, 2025 | Sell | 1,054 | $0.78 | $820 |
| Douglas Carr | Feb 3, 2025 | Sell | 351 | $0.78 | $270 |
| Adrienne Farid | Nov 4, 2024 | Sell | 1,033 | $1.23 | $1,300 |
| Douglas Carr | Nov 4, 2024 | Sell | 283 | $1.23 | $350 |
Frequently Asked Questions: Century Therapeutics Insider Trading
In the past 90 days, Century Therapeutics insiders have made 0 buys and 5 sells. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by Gregory Russotti who sold 2,587 shares on September 14, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Cowan Chad has bought the most IPSC stock in the last 2 years, with a total value of $49,000.
Pfeiffenberger Brent has sold the most IPSC stock in the last 2 years, with a total value of $60,000.
The total value of insider transactions for Century Therapeutics in the last 2 years is negative, amounting to -$46,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
